Recent Posts
- BioXcel planning pivotal trial of BXCL501 for Alzheimer’s agitation April 18, 2024
- NK cell therapy seen to slow cognitive decline in Phase 1 trial April 11, 2024
- Facing an Alzheimer’s diagnosis and caregiving is scary, but doable April 8, 2024
- Eisai seeks FDA approval of Leqembi IV maintenance dosing April 4, 2024
- Voyager’s tau-reducing therapies show promise in preclinical studies March 28, 2024